Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by askretkaon Jul 13, 2023 11:03pm

282 Views

Post# 35540611

Pancan adds 4 new members to their BOD

Our new partner PanCan has added 4 new members to their BOD with some pretty impressive credentials.

https://pancan.org/news/pancan-welcomes-four-new-members-to-the-board-of-directors/?utm_source=social%2Bmedia&utm_medium=social&utm_campaign=bod&utm_term=general%2Bpublic&utm_content=general%2Bpost

Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it